...
机译:BH3模拟物拮抗有限的生存Bcl-2蛋白代表另一类选择性免疫调节药物
Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnlmmunology Division The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnlmmunology Division The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnAutoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnAutoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnMolecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia Department of Microbiology and Immunology, University of Melbourne, Parkville 3010, Australia;
rnMolecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnAutoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
rnlmmunology Division The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia;
apoptosis; immunity; memory; transplantation;
机译:BH3模拟物ABT-737靶向选择性Bcl-2蛋白,如果Mcl-1被中和,则可通过Bak / Bax有效诱导凋亡。
机译:Bcl-2蛋白家族作为癌症化疗的药物靶标:BH3模拟物从实验台到床头的漫长路途
机译:B细胞淋巴瘤-2(BCL-2)同源结构域3(BH3)模拟物证明了依赖于副和抗凋亡Bcl-2家族蛋白的功能性曲目的差异活性
机译:基于Tris-Benzamides的α-Helix模拟物抑制抗凋亡Bcl-2家族蛋白
机译:靶向抗凋亡BCL-2蛋白,具有基于氏菌毒素的BH3结构域模拟物
机译:BH3模拟物拮抗有限的生存Bcl-2蛋白代表另一类选择性免疫调节药物
机译:BH3模拟物拮抗有限的生存Bcl-2蛋白代表另一类选择性免疫调节药物